Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Inflammation, atrophy, and gastric cancer
James G. Fox, Timothy C. Wang
James G. Fox, Timothy C. Wang
Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):60-69. https://doi.org/10.1172/JCI30111.
View: Text | PDF
Review Series

Inflammation, atrophy, and gastric cancer

  • Text
  • PDF
Abstract

The association between chronic inflammation and cancer is now well established. This association has recently received renewed interest with the recognition that microbial pathogens can be responsible for the chronic inflammation observed in many cancers, particularly those originating in the gastrointestinal system. A prime example is Helicobacter pylori, which infects 50% of the world’s population and is now known to be responsible for inducing chronic gastric inflammation that progresses to atrophy, metaplasia, dysplasia, and gastric cancer. This Review provides an overview of recent progress in elucidating the bacterial properties responsible for colonization of the stomach, persistence in the stomach, and triggering of inflammation, as well as the host factors that have a role in determining whether gastritis progresses to gastric cancer. We also discuss how the increased understanding of the relationship between inflammation and gastric cancer still leaves many questions unanswered regarding recommendations for prevention and treatment.

Authors

James G. Fox, Timothy C. Wang

×

Figure 3

H. pylori induces proinflammatory responses in epithelial cells by 2 pathways.

Options: View larger image (or click on image) Download as PowerPoint

H. pylori induces proinflammatory responses in epithelial cells by 2 pa...
H. pylori–induced proinflammatory responses are dependent on the presence in H. pylori of a functional type IV secretion system (T4SS), which delivers effector molecules, such as cell wall peptidoglycan (PGN) and the protein CagA, to epithelial cells. The precise mechanisms by which the H. pylori T4SS mediates effector delivery to host cells are, however, presently unknown. (i) Recognition of H. pylori PGN by the cytosolic host defense molecule NOD1 leads to NF-κB activation. On the basis of studies with Shigella flexneri, it is likely that NOD1 activates NF-κB via caspase-recruitment domain (CARD)–CARD interactions with receptor-interacting serine-threonine kinase (RICK; also known as RIP2). Activated NF-κB complexes translocate to the nucleus, where they upregulate expression of genes encoding the proinflammatory chemokines IL-8 and CXC-chemokine ligand 2 (CXCL2; also known as MIP2) and the antimicrobial peptide human β-defensin-2 (hBD-2). (ii) CagA translocation into epithelial cells by certain H. pylori strains able to induce high levels of IL-8 is also accompanied by the induction of an inflammatory response. Tyrosine phosphorylation of EPIYA motifs on CagA triggers a signaling cascade that involves the Ras-dependent kinases ERK1 and ERK2, leading to activation of the transcription factors NF-κB and activator protein-1 (AP-1) and, ultimately, IL-8 production by host cells. Courtesy of R. Ferrero (Monash University, Clayton, Victoria, Australia).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts